Sirolimus Prolonged Survival After Living Donor Liver Transplantation for HCC Beynd Milan Criteria; Outcome of a Multicenter Prospective Randomized Phase II Trial (ClinicalTrials. gov Identifier: NCT01374750)

被引：0

|

作者：

Lee, K. -W. ^{[1
]}

Kim, S. -H. ^{[2
]}

Yi, N. -J. ^{[1
]}

Hong, S. -K. ^{[1
]}

Yoon, G. ^{[1
]}

Kim, H. ^{[1
]}

Oh, D. ^{[1
]}

Han, S. -S. ^{[2
]}

Park, S. -J. ^{[2
]}

Suh, K. -S. ^{[1
]}

机构：

[1] Seoul Natl Univ, Dept Surg, Seoul, South Korea

[2] Natl Canc Ctr, Ctr Liver Canc, Goyangsi, South Korea

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

25

引用

收藏

页码：215 / 216

页数：2

相关论文

共 3 条

[1] Sirolimus Prolonged Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Exceeding Milan Criteria; Outcome of a Multicenter Prospective Randomized Control Phase II Trial
Lee, K. -W
Yoon, K. C.
Hong, S. K.
Kim, S. -H.
Yi, N. -J
Park, S. -J
Han, S. -S
Suh, K. -S
TRANSPLANTATION, 2017, 101 (05) : 17 - 17
[2] Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial
Lee, Kwang-Woong
Kim, Seong Hoon
Yoon, Kyung Chul
Lee, Jeong-Moo
Cho, Jae-Hyung
Hong, Suk Kyun
Yi, Nam-Joon
Han, Sung-Sik
Park, Sang-Jae
Suh, Kyung-Suk
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (10) : 1 - 11
[3] Two years Rituximab maintenance vs. observation after first line treatment with bendamustine plus rituximab (B-R) in patients with mantle cell lymphoma: first results of a prospective, randomized, multicenter phase 2 study (a subgroup study of the StiL NHL7-2008 MAINTAIN trial; Clinicaltrials.gov Identifier: NCT00877214)
Rummel, M.
Knauf, W.
Goemer, M.
Soeling, U.
Lange, E.
Hertenstein, B.
Eggert, J.
Schliesser, G. C.
Weide, R.
Blumenstengel, K.
Detlefsen, N.
Hinke, A.
Kauff, F.
Barth, J.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 118 - 118